[125I]NKA (human, mouse, rat) [7722]
[125I]NKA (human, mouse, rat)
| SMILES |
CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)C(C)C)C(N)=O |
| InChIKey |
HEAUFJZALFKPBA-JPQUDPSNSA-N |
| Sequence |
HKTDSFVGLM |
| HELM |
PEPTIDE1{H.K.T.D.S.F.V.G.L.M.[am]}$$$$ |
Chemical Properties
| Hydrogen bond acceptors |
17 |
| Hydrogen bond donors |
16 |
| Rotatable bonds |
37 |
| Log P |
-4.566 |
| Molecular weight (Da) |
1132.6 |
| Stereochemistry info |
partial |
| Radioactive |
125I |
Bioactivities
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
[125I]NKA (human, mouse, rat)
Drug properties
| Molecular type |
Peptide |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Compound is not listed as a drug.